Crossmark

Complete remission of an early-stage laryngeal cancer under combined pembrolizumab and chemotherapy treatment of a synchronous lung adenocarcinoma

Published Online: 2022-05-16

Published Print: 2022-12

Authors

Linxweiler, Maximilian http://orcid.org/0000-0002-5028-9282
Kühn, Jan Philipp

Neubert, Christian

Khreish, Fadi

Balensiefer, Benedikt

Wagner, Mathias

Schick, Bernhard
Funding

Funding for this research was provided by:

Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
License Information

Text and Data Mining valid from 2022-05-16

Version of Record valid from 2022-05-16
More Information

Article History

Received: 23 October 2021

Accepted: 31 March 2022

First Online: 16 May 2022

Declarations

:

: This retrospective case study was in accordance with the ethical standards of the institutional and national research committee (index number 21810) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The patient gave his informed consent to participate.

: The patient gave his informed consent for publication of clinical data and images.

: None to declare.

Document is current